Once-Weekly Insulins: A New Frontier in Type 2 Diabetes Management is organized by Pri-Med.
Release Date: 01/31/2025
Expiration Date: 01/31/2026
Description:
Discover how once-weekly insulins are reshaping type 2 diabetes mellitus (T2DM) care in this interactive module led by diabetes experts. Together they explore the clinical data, unique dosing, and potential benefits these investigational agents have for patients with T2DM.
Learning Objectives:
Topics:
Accreditation Statement
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
Pri-Med Institute designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AANP
Accreditation Statement
Pri-Med Institute is accredited by the American Association of Nurse Practitioners® as an approved provider of nurse practitioner continuing education. Provider number: 040308.
Designation Statement
This activity is approved for 0.28 contact hour, which includes 0.28 hour of pharmacology.
MOC Credit Information
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved